Q1 2026 Palatin Technologies Inc Earnings Call Transcript

Nov 13, 2025 / 04:00 PM GMT

Release Date Price: €3.3

Transcript 10-Q

Key Points

Positve

Palatin Technologies Inc (PTN) executed a significant research collaboration and license agreement with Brangel Engelheim, receiving an upfront payment of approximately $2.3 million and achieving a $6.5 million research milestone.
The company successfully closed an upsized $18.2 million underwritten public offering, regaining compliance with NYSE American continued listing standards.
Palatin Technologies Inc (PTN) reported a net income of $4.7 million for the quarter ended September 30, 2025, compared to a net loss of $7.8 million in the same quarter last year.
The company's operating expenses decreased significantly to $4.2 million from $7.8 million in the comparable quarter last year, mainly due to reduced spending on development programs.
Palatin Technologies Inc (PTN) has a promising pipeline with the development of highly selective melanocortin 4 receptor agents for obesity treatment, with potential for reduced side effects and increased efficacy.

Negative

Palatin Technologies Inc (PTN) reported a low cash and cash equivalents position of $1.3 million as of September 30, 2025, although this does not include recent milestone payments and offering proceeds.
The company's future success is heavily reliant on the successful development and commercialization of its pipeline products, which are still in early stages.
There is no guarantee that the Series J warrants will be exercised, which could impact the company's expected additional proceeds.
Palatin Technologies Inc (PTN) faces competition in the obesity treatment market, with established players already present.
The company's financial performance is significantly dependent on milestone achievements and collaborations, which carry inherent risks and uncertainties.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PTN.A - Palatin Technologies Inc
Q1 2026 Palatin Technologies Inc Earnings Call
Nov 13, 2025 / 04:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings. Welcome to Palatine's first quarter fiscal year 2026 operating results conference call.

At this time all participants are on the listen-only mode. A question-and-answer session will follow the formal presentation.

If anyone should require operator assistance during the conference, please press 0 on your telephone keypad.

As a reminder, this conference call is being recorded.

Before we begin our remarks, I'd like to remind you that statements made by Palatin are not historical facts and may be forward-looking statements.

These statements are based on assumptions that may or may not prove accurate and that the actual results may differ materially from those anticipated

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.